Clinical trial
Efficacy of Psidii Guava's Extract For Mild And Symptomless Coronavirus Disease-19 (COVID-19)
NCT04810728 is registered in ClinicalTrials.gov with Baiturrahmah University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Psidii Guava's Extract For Mild And Symptomless Coronavirus Disease-19 (COVID-19)
- Lead sponsor
- Baiturrahmah University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 20, 2020
- Completion date
- January 30, 2021
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19